Back to
DRIEHAUS CAPITAL MANAGEMENT LLC
RETAShowing 0 of 8 quarters
Position history for
DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in REATA PHARMACEUTICALS INC-A
As of its Q2 2023 13F, Driehaus Capital Management held 94,945 shares of RETA (Reata Pharmaceuticals), worth $9.7M. RETA was 0.1% of Driehaus Capital Management's reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of RETA: WELLINGTON MANAGEMENT GROUP LLP